PATENT CLAIM ANALYSIS

Application Number: 16161801
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-07
Patent Classification: ["604", "093010"]

Abstract:
A wearable system detects an opioid overdose and transmits a distress message with the wearer's GPS coordinates to one or more emergency response contacts. Concurrently, the system signals a switch which energizes a solenoid injector, causing a prescribed dosage of an opioid antidote to be injected by a syringe into the wearer's body. Detection of an opioid overdose is based on one or more symptomatic biometrics, which are measured by a wearable monitor. The monitor unit and the injector units can be separate, or they can be combined in a single unit.

Claim (Index 1):
A wearable system for detecting an opioid overdose and automatically administering to a wearer a dosage injection of an opioid antidote, the system comprising:\n a wearable monitor unit, comprising one or more biometric monitors, a GPS receiver, a monitor microprocessor, and a wireless telephone transmitter; a wearable injector unit, comprising a solenoid switch, an electrical power source, a solenoid having an armature and a solenoid core, a syringe containing a prescribed dosage of the opioid antidote, a hypodermic needle, and a syringe assembly, wherein the syringe has a plunger and an outlet of the syringe is connected to the hypodermic needle through a flexible connection tubing, and wherein the syringe assembly comprises at least one plunger spring connected to the plunger and a release latch connected to the plunger, and wherein the solenoid is electrically connected to the electrical power source through the solenoid switch; wherein the injector unit further comprises a needle carriage, which carries the hypodermic needle along a carriage track, and wherein the armature of the solenoid has a proximal end, which is closer to the solenoid core, and a distal end, which is further from the solenoid core, and wherein the distal end of the armature is connected to the needle carriage by a carriage bracket; wherein the monitor unit is configured to be attached to the wearer, such that each of the biometric monitors continuously monitors wearer biometric data and continuously transmits the wearer biometric data to the monitor microprocessor; wherein the monitor microprocessor is programmed to continuously compare the wearer biometric data with one or more pre-set thresholds indicative of an opioid overdose; wherein the monitor microprocessor is programmed, upon determining that the wearer biometric data is indicative of an opioid overdose, to obtain current wearer location coordinates from the GPS receiver and to send one or more emergency messages, including the current wearer location coordinates, to one or more emergency contacts using the wireless telephone transmitter; wherein the monitor microprocessor is programmed, upon determining that the wearer biometric data is indicative of an opioid overdose, to transmit an activation signal to the solenoid switch of the injector unit; wherein, upon receiving the activation signal, the solenoid switch is configured to complete an energizing circuit, such that the electrical power source energizes the solenoid of the injector unit; wherein the injector unit is configured so that, when the solenoid is energized, the distal end of the armature, acting though the carriage bracket, pulls the needle carriage toward a needle aperture, through which the hypodermic needle protrudes and inserts into the wearer; wherein the injector unit is configured so that, upon the solenoid being energized, the armature opens the release latch, thereby releasing the plunger and causing the plunger springs to fully depress the plunger, so as to force the prescribed dosage of the opioid antidote out of the syringe, through the connection tubing, into the hypodermic needle, and through the hypodermic needle into the wearer; wherein the injector unit is configured, at an end of a dosage injection, to open the energizing circuit, such that the electrical power source ceases to energize the solenoid and the solenoid is de-energized; and wherein the injector unit is configured, upon the solenoid being de-energized, to retract the hypodermic needle, such that the syringe ceases to inject the opioid antidote into the wearer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.61905
- Patent Class: 604.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12470866', '14123047', '15810482', '10191147', '13886785']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7510916825203565
- 35 USC 102 Novelty (BERT): 0.4659578900329961
- Combined Prediction Score: 0.7225783032716205
- Mean Citation Score: 134.361828
- Max Citation Score: 137.20988
- Similarity Product: 94.04517418057918

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test